Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Go back to Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program| (NASDAQ: DTIL) | Delayed: 7.51 +0.05 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.46 | 52 Week High | $ | |||
| Open | $7.48 | 52 Week Low | $ | |||
| Day High | $7.63 | P/E | N/A | |||
| Day Low | $7.36 | EPS | $ | |||
| Volume | 345,174 | |||||

